Current Research Interest
Dr. Gönen has been at MSK since 1999 and has been serving as Chief of the Biostatistics Service since 2015. His translational and clinical collaborations focus on diagnosis, treatment and surveillance of gastrointestinal cancers. Most of Dr. Gönen’s methodological research originates from these collaborations, including building, assessing and comparing prognostic and predictive models, design and analysis of clinical trials, as well as Bayesian methods. He is the principal investigator of the multi-center, FNIH-supported VOL-PACT project. Dr. Gönen served as co-director of the AACR/ASCO Vail Workshop on Methods in Clinical Cancer Research from 2011 to 2013 and served ASCO and AACR in numerous other roles. He served the Society for Clinical Trials (SCT) in various roles: President, Board Member, Program Chair and Deputy Editor of its journal, Clinical Trials: Journal of the Society for Clinical Trials. Dr. Gönen is a fellow of the American Statistical Association, a fellow of the SCT, a member of the board of reviewing editors for Science in Translational Medicine, a member of the EORTC Protocol Review Committee, and a member of NHLBI’s DSMB for the RECOVER-CT program. He served the International Biometric Society as the Program Chair for its North American Region meeting in 2015.
Visit PubMed for a full listing of Mithat Gönen’s journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.My Downloads
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Mithat Gönen discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures